期刊文献+

益气化痰活血法治疗颈动脉粥样硬化斑块的临床研究 被引量:11

Clinical Observation of Qi-replenishing,Blood-activating and Phlegm-removing Therapy in the Treatment of 60 Cases of Carotid Atherosclerotic Plaques
下载PDF
导出
摘要 目的:观察益气化痰活血法治疗颈动脉粥样硬化斑块的临床疗效。方法:将120例颈动脉粥样硬化斑块患者随机分为治疗组60例与对照组60例,对照组予以拜阿斯匹林肠溶片100mg加瑞舒伐他汀片10mg,睡前服,治疗组在对照组治疗的基础上加服益气化痰活血中药汤剂,每日1剂;两组均治疗6个月后观察临床疗效,治疗前后分别测定两组患者颈动脉内径(CAD)、颈动脉粥样硬化斑块面积、颈动脉内膜中层厚度(IMT)、血脂及中医临床症状等指标。结果:治疗后两组颈动脉CAD增宽、IMT变薄、颈动脉粥样硬化斑块面积缩小,并且血清TC、TG、HDL-C、LDL-C、中医临床症状较治疗前有明显好转,两组治疗前后比较差异有统计学意义(P<0.05)。治疗组在治疗后颈动脉CAD较对照组增宽、IMT较对照组变薄、颈动脉粥样硬化斑块面积较对照组缩小,血清TC、TG、LDL-C、中医临床症状均较对照组改善明显,两组比较差异有统计学意义(P<0.05)。结论:益气化痰活血法治疗颈动脉粥样硬化斑块时,在使颈动脉内径(CAD)增宽、颈动脉IMT变薄、颈动脉粥样硬化斑块面积缩小、改善血脂代谢异常方面起到协同作用,对中医临床症状有明显改善,值得临床推广。 Objectives: To discuss the clinical curative effect of Qi-replenishing, Blood-activating and Phlegm-removing Therapy in treatment of carotid atherosclerotic plaques. Methods: 120 patients with carotid atherosclerotic plaques were chosen as the research objects, and they were randomly divided into the controlled group and the treatment group, with 60 cases in each group. The controlled group was given by Bayaspirin plus rosuvastatin, and the treatment group was given Traditional Chinese Medicine medicinal broth of Qi-replenishing, Blood-activating and Phlegm-removing on the basis of the controlled group. The intima-media-thickness (IMT), carotid artery CAD, carotid plaque area, TC, TG, HDL-C, LDL-C and clinical syndrome of the patients of two groups before and after treatment were measured. Results: After treatment, carotid artery CAD of the two groups was broadening, IMT was thinning, carotid plaque area was reduced, and the serum TC, TG, HDL-C, LDL-C and clinical syndrome were better than that before the treatment, the effect of the two groups before and after treatment had significant difference (P 〈 0. 05). Comparing the two groups after treatment, carotid CAD of the treatment group was wider than that of the controlled group, IMT of the treatment group was thinner than that of the controlled group, and the carotid plaque area of the treatment was smaller than that of the controlled group, and the serum TC, TG, LDL-C and clinical syndrome of the treatment group were better than those of the controlled group, there were significant differences between the two groups ( P 〈 0. 05 ). Conclusion : In the treatment of carotid atherosclerotic plaques, Qi-replenishing, Blood-activating and Phlegm-removing thera- py play a synergistic effect in broadening the carotid artery diameter, thinning the carotid artery IMT, reducing the carotid plaque area, improving blood lipid metabolism abnormalities and clinical syndrome, and they are worthy of clinical application.
作者 曹晓玲 王燕
出处 《四川中医》 2013年第12期69-72,共4页 Journal of Sichuan of Traditional Chinese Medicine
关键词 颈动脉粥样硬化斑块 中药汤剂 益气化痰活血法 瑞舒伐他汀片+拜阿斯匹林肠溶片 Carotid atherosclerotic plaques Traditional Chinese Medicine medicinal broth Qi-replenishing, Blood-acti-vating and Phlegm-removing therapy Bayaspirin plus rosuvastatin
  • 相关文献

参考文献6

  • 1张敬芳,杨雪琴,张学福.黄芪多糖抗动脉粥样硬化作用及其机制的研究[J].中国动脉硬化杂志,2011,19(3):268-268. 被引量:7
  • 2王伟,杨滨,王岚,梁日欣,陈承瑜,胡楠,成龙,杨艳,殷小杰,高双荣,叶锦霞.丹参山楂药对对大鼠动脉粥样硬化的影响[J].中国中药杂志,2011,36(6):784-789. 被引量:60
  • 3张璐,薛梅,马晓娟,杨琳,殷惠军.赤芍川芎有效部位对兔动脉粥样硬化基质金属蛋白酶的影响[J].中国中西医结合杂志,2009,29(6):514-518. 被引量:21
  • 4Joseph A Vita,Noyan Gokce,Stephen J Duffy,David Kahn,Douglas Tomasian,Joseph Palmisano,Shane Thomas,Monika Holbrook,John F Keaney.Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease[J].The American Journal of Cardiology.2003(7)
  • 5Bertram Pitt,Robert P. Byington,Curt D. Furberg,Donald B. Hunninghake,G. B. John Mancini,Michael E. Miller,Ward Riley.Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events[J].Circulation: Journal of the American Heart Association.2000(13)
  • 6Mookadam Farouk,Tanasunont Weerawat,Jalal Uzma,Mookadam Martina,Wilansky Susan.Carotid intima-media thickness and cardiovascular risk[].Future cardiology.2011

二级参考文献26

  • 1许涛,喻莉,郑智,李树生.丹参对实验性动脉粥样硬化形成的预防[J].临床心血管病杂志,2005,21(1):54-55. 被引量:58
  • 2韩晓枫,张威,赵益明.高脂饲料加球囊扩张动脉粥样硬化兔腹主动脉模型的建立[J].临床和实验医学杂志,2006,5(11):1679-1680. 被引量:6
  • 3徐浩,文川,陈可冀,史大卓,刘剑刚.川芎、赤芍及其有效部位配伍对载脂蛋白E基因缺陷小鼠动脉粥样硬化斑块稳定性影响的研究[J].中国中西医结合杂志,2007,27(6):513-518. 被引量:27
  • 4Arora S, Nicholls SJ. Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis[J]. Drugs Todays ( Barc), 2008,44 (9) :711 - 718.
  • 5Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome [J]. Cardiovasc Res,2006,69(3) :636-645.
  • 6Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases, structure, function, and biochemistry [J]. Circ Res, 2003,92 (8) :827-839.
  • 7Faia KL, Davis WP, Marone A J, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography [ J ]. Atherosclerosis, 2002, 160 (2) :325-337.
  • 8Carrell TW, Burnand KG, Wells GM, et al. Stromely sin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms [ J ]. Circulation, 2002,105(4) .477-482.
  • 9Abilleira S, Bevan S, Markus HS. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis [J]. J Med Genet, 2006,43 (12) :897-901.
  • 10Pollanen P J, Lehtimaki T, Mikkelsson J, et al. Matrixmetalloproteinase-3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques [ J ]. Atherosclerosis, 2005,180(1 ) :73-78

共引文献84

同被引文献182

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部